Search Results 881-890 of 17598 for Assay

1. Study of Iopofosine I 131 (CLR 131) in Select B-Cell Malignancies (CLOVER-1) and Pivotal Expansion in Waldenstrom Macroglobulinemia (CLOVER-WaM) - Mayo Clinic

   - Serum FLC assay: Involved FLC level ≥ 10 mg/dL provided serum FLC ratio is abnormal. [CLOSED] Patients with Chronic Lymphocytic Leukemia/ Small ...

2. Nizubaglusta in Late-Infantile and Juvenile Forms of Niemann-Pick Type C Disease and GM1 Gangliosidosis or GM2 Gangliosidosis - Mayo Clinic

   ... assay on two different blood samples; Genetic test: presence of biallelic pathogenic or likely pathogenic variants according to the American College of ...

3. Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane with or without Chemotherapy in Treating Patients with Invasive RxPONDER Breast Cancer - Mayo Clinic

   ... Assay has not been performed, patients must be willing to submit tissue samples for testing to determine the Recurrence Score value; a representative block ...

4. INCB161734 for Advanced or Metastatic Solid Tumors With KRAS G12D Mutation - Mayo Clinic

   ... assay having a relevant mark of conformity for analytical performance (eg, CLIA [US] or UKCA, CE, CE UKNI, or others) to be eligible. Disease progression on ...

5. Testing wastewater for COVID-19: The clearest path to understanding community infection - Mayo Clinic News Network

   ... assay at the end to detect a different pathogen." For the safety of its patients, staff and visitors, Mayo ...

6. S1602: Different Strains of BCG With or Without Vaccine in High Grade Non- Muscle Invasive Bladder Cancer - Mayo Clinic

   If PPD is not available, then a negative Interferon Gamma Release Assay (IGRA) may be used. The PPD or IGRA test results must be obtained within 90 days ...

7. Presatovir in Hematopoietic Cell Transplant Recipients With Respiratory Syncytial Virus Infection of the Upper Respiratory Tract - Mayo Clinic

   Documented to be RSV-positive as determined by local testing (eg, polymerase chain reaction, direct fluorescence antibody, respiratory viral panel assay, or ...

8. A Study Of IDRX-42 Versus Sunitinib In Participants With Metastatic And/or Unresectable Gastrointestinal Stromal Tumors (GIST) After Imatinib Therapy (StrateGIST 3) - Mayo Clinic

   Locally assessed mutation status of KIT/PDGFRA must be available for patient stratification, using a tissue-based next-generation sequencing (NGS) or PCR assay.

9. Cancer Clinical Trials - Mayo Clinic Research

   ... assays to those obtained by orthogonal methods, including tissue-based assays and results from a ctDNA assay by Guardant on blood. A Study to Assess ...

10. A Study to Evaluate the Disease Development and Impact of Intravascular Volume Expansion Profiles in Relation to Neuroendocrine and Renal Function in Post-Acute Heart Failure - Mayo Clinic

    ... assay to the laboratory that developed the equation. The 4-variable equation from the Modification of Diet in Renal Disease (MDRD) Study has been ...